South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks

GC Biopharma

Market Cap: ₩1.6t

A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.

ST PharmLtd

Market Cap: ₩1.8t

Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.

Hanall Biopharma

Market Cap: ₩1.6t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

L&C BIOLTD

Market Cap: ₩1.5t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

D&D Pharmatech

Market Cap: ₩2.0t

A clinical-stage biotech company, develops medicines in South Korea and the United States.

SK bioscienceLtd

Market Cap: ₩3.8t

Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.

Oscotec

Market Cap: ₩1.7t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Hanmi Pharm

Market Cap: ₩4.8t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

Peptron

Market Cap: ₩6.6t

Engages in the development of peptide-based medicines.

PharmaResearch

Market Cap: ₩5.7t

Operates as a biopharmaceutical company primarily in South Korea.

ABL Bio

Market Cap: ₩5.1t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

Celltrion Pharm

Market Cap: ₩2.4t

A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.

Mezzion PharmaLtd

Market Cap: ₩2.0t

Develops, manufactures, and sells pharmaceutical products in South Korea.

ALTEOGEN

Market Cap: ₩24.3t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Hugel

Market Cap: ₩3.2t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

SK Biopharmaceuticals

Market Cap: ₩8.2t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

Kolon TissueGene

Market Cap: ₩4.1t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

Sam Chun Dang Pharm

Market Cap: ₩5.3t

Engages in the manufacturing and sale of pharmaceutical products in South Korea.

Celltrion

Market Cap: ₩39.2t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Samsung BiologicsLtd

Market Cap: ₩72.7t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Caregen

Market Cap: ₩3.0t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

OliX Pharmaceuticals

Market Cap: ₩1.9t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

LigaChem Biosciences

Market Cap: ₩5.3t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

Yuhan

Market Cap: ₩8.8t

Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.

Voronoi

Market Cap: ₩2.8t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.

Daewoong Pharmaceutical

Market Cap: ₩1.6t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.